日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Saccharophagus degradans Undecaprenyl-diphosphatase (uppP), partial CSB-YP630392SAAX
CSB-EP630392SAAX
CSB-BP630392SAAX
CSB-MP630392SAAX
CSB-EP630392SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Orotidine 5'-phosphate decarboxylase (pyrF) CSB-YP630393SAAX
CSB-EP630393SAAX
CSB-BP630393SAAX
CSB-MP630393SAAX
CSB-EP630393SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Tetraacyldisaccharide 4'-kinase (lpxK) CSB-YP630394SAAX
CSB-EP630394SAAX
CSB-BP630394SAAX
CSB-MP630394SAAX
CSB-EP630394SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Cytochrome c-type biogenesis protein CcmE (ccmE), partial CSB-YP630395SAAX
CSB-EP630395SAAX
CSB-BP630395SAAX
CSB-MP630395SAAX
CSB-EP630395SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans LexA repressor (lexA) CSB-YP630396SAAX
CSB-EP630396SAAX
CSB-BP630396SAAX
CSB-MP630396SAAX
CSB-EP630396SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Protein CrcB homolog (crcB), partial CSB-YP630397SAAX1
CSB-EP630397SAAX1
CSB-BP630397SAAX1
CSB-MP630397SAAX1
CSB-EP630397SAAX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Acyl carrier protein (acpP) CSB-YP630398SAAX
CSB-EP630398SAAX
CSB-BP630398SAAX
CSB-MP630398SAAX
CSB-EP630398SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans UPF0345 protein Sde_1594 (Sde_1594) CSB-YP630399SAAX
CSB-EP630399SAAX
CSB-BP630399SAAX
CSB-MP630399SAAX
CSB-EP630399SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Glutamate--tRNA ligase (gltX), partial CSB-YP630400SAAX
CSB-EP630400SAAX
CSB-BP630400SAAX
CSB-MP630400SAAX
CSB-EP630400SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans S-adenosylmethionine:tRNA ribosyltransferase-isomerase (queA) CSB-YP630401SAAX
CSB-EP630401SAAX
CSB-BP630401SAAX
CSB-MP630401SAAX
CSB-EP630401SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Fructose-1,6-bisphosphatase class 1 (fbp) CSB-YP630402SAAX
CSB-EP630402SAAX
CSB-BP630402SAAX
CSB-MP630402SAAX
CSB-EP630402SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans 50S ribosomal protein L19 (rplS) CSB-YP630403SAAX
CSB-EP630403SAAX
CSB-BP630403SAAX
CSB-MP630403SAAX
CSB-EP630403SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Ribosomal RNA large subunit methyltransferase M (rlmM) CSB-YP630404SAAX
CSB-EP630404SAAX
CSB-BP630404SAAX
CSB-MP630404SAAX
CSB-EP630404SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Pantothenate synthetase (panC) CSB-YP630405SAAX
CSB-EP630405SAAX
CSB-BP630405SAAX
CSB-MP630405SAAX
CSB-EP630405SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans 50S ribosomal protein L21 (rplU) CSB-YP630406SAAX
CSB-EP630406SAAX
CSB-BP630406SAAX
CSB-MP630406SAAX
CSB-EP630406SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans 30S ribosomal protein S11 (rpsK) CSB-YP630407SAAX
CSB-EP630407SAAX
CSB-BP630407SAAX
CSB-MP630407SAAX
CSB-EP630407SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans 30S ribosomal protein S8 (rpsH) CSB-YP630408SAAX
CSB-EP630408SAAX
CSB-BP630408SAAX
CSB-MP630408SAAX
CSB-EP630408SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans 50S ribosomal protein L22 (rplV) CSB-YP630409SAAX
CSB-EP630409SAAX
CSB-BP630409SAAX
CSB-MP630409SAAX
CSB-EP630409SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Elongation factor G 2 (fusA2), partial CSB-YP630410SAAX
CSB-EP630410SAAX
CSB-BP630410SAAX
CSB-MP630410SAAX
CSB-EP630410SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans 50S ribosomal protein L1 (rplA) CSB-YP630411SAAX
CSB-EP630411SAAX
CSB-BP630411SAAX
CSB-MP630411SAAX
CSB-EP630411SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×